https://www.selleckchem.com/pr....oducts/srt2104-gsk22
The results have been evaluated by herbal medicine experts' domain knowledge.Background Cardio-renal profiles are available from cardiovascular outcome trials of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Methods A comprehensive systematic review of Embase, Medline, Web of Knowledge, and CENTRAL databases was conducted. Randomized controlled cardiovascular outcome trials of type 2 diabetes mellitus (T2DM) patients administered GLP-1 RAs were included. The following primary outcomes were examined cardiovascular dea
Like
Comment
Share
